A recent report by Precedence Research estimates the global market size for implantable medical devices will grow from USD 97.62 Billion in 2024 to USD 178.15 Billion by 2034:
The rapid increase in the global market size of implantable medical devices is already resulting in technological advancements in this field. For example, TANAKA Precious Metals Technologies has announced the launch of its Visi Fine ® series, a group of highly radiopaque precious metal materials that can be used for medical device components.
“The brand name Visi Fine® is a coined term combining “Visi” (visible) and “Fine” (fine and refined materials). The concept is to provide substances with excellent X-ray impermeability, crafted into highly reliable materials for medical device components using advanced processing technology,” according to TANAKA’s press release.
Components used in medical devices, such as catheterization devices and implantable medical devices, typically must possess unique characteristics. For example, they often exhibit low reactivity with bodily tissues and include visibility under X-ray imaging to accurately determine the position of a medical device within the body. Platinum, Gold, and Titanium are some examples of materials that are used in medical devices and can be in contact with parts of the body for extended periods of time. FDA has released some of the information it considers when evaluating the safety of materials in medical devices, which includes the specific properties of the material, the intended use of the device, and the function of the device.
